Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Research in Temporal Arteritis Suggests Link with Infection, Autoimmune Disease

Shamik Bhattacharyya, MD, MS  |  Issue: November 2015  |  November 16, 2015

The current publication is certainly not the first suggestion that VZV or other infections might be important in the pathogenesis of GCA. In fact, as the authors acknowledge, at least seven prior studies have searched for VZV in arteries affected by GCA.5 Many of these studies were negative. For example, in 2014, Ami Bhatt, MD, and colleagues analyzed 12 formalin-fixed temporal artery biopsy specimens with GCA for microbes using comprehensive DNA sequencing compared to five controls.6 They did not find pathogenic viruses, including VZV.

In 2004, Rodriguez-Pla and colleagues used PCR to search for VZV DNA in 50 temporal artery biopsies showing histologic features of GCA.7 None were positive.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

On the other hand, some smaller studies have suggested an association between VZV and GCA. For example, in a 2001 study of 35 specimens of GCA, 26% showed evidence of VZV using PCR compared with none in controls.8

Sampling Error?

The question remains whether the current study, which is larger than any of the previous investigations, definitively advances our understanding of GCA or is yet another inconclusive finding in the long-running debate about GCA and VZV.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

One of the strengths of this study is how comprehensively the histological sections were analyzed. The authors not only studied sections showing GCA pathology but also analyzed the skip areas for the presence of VZV. As it turned out, VZV-positive regions tended to be adjacent to GCA pathology rather than being part of it. Secondly, the authors performed PCR selectively on regions that were positive for VZV using immunohistochemistry techniques. Because VZV-positive regions have intervening gaps, it’s possible the mixture of positive and negative VZV PCR publications reflects the substantial sampling error when trying to detect VZV. The one electron micrograph presented that shows enveloped viral particles is hard to ignore.

However, the study is cross-sectional, and we can say that there may be an association between VZV and GCA rather than causation. Also, the controls were from autopsy and obtained from different conditions than the temporal arteritis samples.

If we are to believe the authors’ argument that VZV is causative of GCA secondary to VZV reactivation in the cranial ganglia followed by axonal spread to the arterial adventitia, how do we reconcile the apparent brisk therapeutic response of GCA to high-dose corticosteroids? Although it’s possible the clinical symptoms are caused primarily by an inflammatory reaction to a self-limited viral reactivation, one would expect that treatment with steroids would ultimately lead to more disseminated infection. Examples of steroid-refractory GCA exist, but in the majority of cases, treatment with steroids over months leads to control of symptoms rather than deterioration.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic ConditionsResearch RheumVasculitis Tagged with:Autoimmune diseaseCauseGiant Cell ArteritisInfectionResearchrheumatologytemporal arteritisvaricella zoster virus

Related Articles

    Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

    March 1, 2013

    Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

    Updates on Giant Cell Arteritis

    March 19, 2018

    SAN DIEGO—Recent research tells us more about giant cell arteritis (GCA) to help rheumatologists more accurately diagnose and effectively treat patients with this type of vasculitis. On Nov. 6 at the ACR/ARHP Annual Meeting, three experts explored the latest findings on GCA pathogenesis, diagnostic approaches, imaging modalities and growing treatment options. GCA: What’s Really Happening?…

    Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

    Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

    November 14, 2021

    Giant cell arteritis (GCA) is a granulomatous vasculitis of large- and medium-sized arteries, usually affecting the cranial branches of the aortic arch. It is the most common vasculitis, with the highest risk factor being age. Accurate diagnosis and prompt initiation of therapy are of great importance to prevent serious complications, with the most feared being…

    Giant Cell Arteritis Challenging to Diagnose, Manage

    March 1, 2015

    Common form of primary vasculitis difficult to identify, treat, but latest research suggests potential new therapeutic targets

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences